Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)
Clinical trial NCT04456023 · WITHDRAWN
Trial details
- NCT number
- NCT04456023
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2022-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.